share_log

12 Health Care Stocks Moving In Monday's Pre-Market Session

Benzinga ·  Mar 18 21:05

Gainers

  • Applied DNA Sciences (NASDAQ:APDN) stock moved upwards by 33.1% to $0.49 during Monday's pre-market session. The market value of their outstanding shares is at $8.3 million.
  • XTL Biopharmaceuticals (NASDAQ:XTLB) shares increased by 19.31% to $1.05. The market value of their outstanding shares is at $5.7 million.
  • 2seventy bio (NASDAQ:TSVT) shares rose 17.7% to $4.72. The company's market cap stands at $242.1 million.
  • DBV Technologies (NASDAQ:DBVT) shares moved upwards by 13.92% to $0.9. The company's market cap stands at $173.1 million.
  • Elicio Therapeutics (NASDAQ:ELTX) shares increased by 13.2% to $5.66. The market value of their outstanding shares is at $54.3 million.
  • Moleculin Biotech (NASDAQ:MBRX) stock rose 12.53% to $0.56. The company's market cap stands at $18.5 million.

Losers

  • Titan Pharma (NASDAQ:TTNP) shares declined by 18.2% to $7.6 during Monday's pre-market session. The market value of their outstanding shares is at $5.7 million.
  • Biophytis (NASDAQ:BPTS) stock fell 14.6% to $0.41. The market value of their outstanding shares is at $3.9 million.
  • Molecular Templates (NASDAQ:MTEM) shares decreased by 14.19% to $2.36. The company's market cap stands at $12.6 million.
  • Nanobiotix (NASDAQ:NBTX) shares fell 9.36% to $6.3. The market value of their outstanding shares is at $296.8 million.
  • TC BioPharm (Holdings) (NASDAQ:TCBP) stock fell 8.92% to $1.53. The company's market cap stands at $3.7 million.
  • Trxade Health (NASDAQ:MEDS) shares decreased by 8.82% to $26.26. The company's market cap stands at $31.6 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment